Company: ALCE
Filing Date: 2025-01-27
Form Type: S-1
Source: 0001213900-25-007054
Chunk: 71

Company: Alternus Clean Energy, Inc.
Filing Date: 2025-01-27
Form: S-1
Chunk 71
---
 per share (150% of the assumed offering price per Common Unit), subject to adjustment, from time to time, until the [●] year anniversary from the date of Warrant Stockholder Approval, after which date any unexercised Series B Warrants will expire and have no further value. The Warrants may not be exercised until we receive the Warrant Stockholder Approval. Under Nasdaq listing rules, the Warrants may not be exercised unless and until we obtain the Warrant Stockholder Approval. While we intend to promptly seek stockholder approval, there is no guarantee that the Warrant Stockholder Approval will ever be obtained. If we are unable to obtain the Warrant Stockholder Approval, the Warrants will have substantially less value. In addition, we will incur substantial costs, and management will devote substantial time and attention, in attempting to obtain the Warrant Stockholder Approval. Since the Pre-Funded Warrants and Warrants are executory contracts, they may have no value in a bankruptcy or reorganization proceeding. In the event a bankruptcy or reorganization proceeding is commenced by or against us, a bankruptcy court may hold that any unexercised Warrants or Pre-Funded Warrants are executory contracts that are subject to rejection by us with the approval of the bankruptcy court. As a result, holders of the Warrants and Pre-Funded Warrants may, even if we have sufficient funds, not be entitled to receive any consideration for their Warrants or Pre-Funded Warrants or may receive an amount less than they would be entitled to if they had exercised their Warrants or Pre-Funded Warrants prior to the commencement of any such bankruptcy or reorganization proceeding. 35 You will experience immediate and substantial dilution in the net tangible book value per share of the common stock included in the Common Units and Pre-Funded Units. The effective price per share of common stock included in the Common Units and Pre-Funded Units is substantially higher than the net tangible book value per share of our common stock outstanding prior to this offering. Assuming the sale of all Common Units in this offering and no sale of any Pre-Funded Units, if you purchase Common Units in this offering, you will suffer immediate and substantial dilution of $[ ●] per share, with respect to the net tangible book value of the common stock as of September 30, 2024. See the section titled “ Dilution” below for a more detailed discussion of the dilution you will incur if you purchase Common Units in this offering. Stockholders may